Completed NA INTERVENTIONAL 2-arm NCT05458362

Brief Enhanced Anxiety Sensitivity Treatment (Group) (Group BEAST)

Efficacy of the Mobile App Augmentation to a Brief Anxiety Sensitivity Treatment

Sponsor: Ohio University

Interventions Brief Enhanced Anxiety Sensitivity Treatment (Group BEAST) Control group Anxiety Sensitivity Treatment

Updated 4 times since 2022 Last updated: Dec 8, 2022 Started: Feb 9, 2022 Primary completion: Jul 4, 2022 Completion: Jul 4, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Anxiety and Anxiety Sensitivity and is currently completed. Ohio University leads this study, which shows 4 recorded versions since 2022 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Sep 2022 — Jan 2023 [monthly]

Recruiting NA

First recorded

Feb 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ohio University

Data source: Ohio University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Athens, United States